NASDAQ:INFI

Infinity Pharmaceuticals SEC Filings & 10K Form

$2.98
-0.10 (-3.25 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.92
Now: $2.98
$3.07
50-Day Range
$2.60
MA: $3.18
$3.64
52-Week Range
$0.78
Now: $2.98
$5.98
Volume871,493 shs
Average Volume3.68 million shs
Market Capitalization$264.15 million
P/E RatioN/A
Dividend YieldN/A
Beta2.4

SEC Filings

Infinity Pharmaceuticals (NASDAQ:INFI) SEC Filings

DateFilerForm TypeView
02/19/2021
4:14 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
4:10 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13G
02/12/2021
3:44 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2021
8:55 PM
Infinity Pharmaceuticals (Filer)
Form S-3MEF
02/11/2021
6:16 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2021
4:27 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
4:26 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13D/A
01/26/2021
11:21 AM
EcoR1 Capital, LLC (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13G
01/06/2021
8:17 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
3:05 PM
Infinity Pharmaceuticals (Issuer)
Tasker Seth A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
8:13 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
4:13 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13D/A
11/09/2020
3:16 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2020
6:41 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2020
5:48 PM
Infinity Pharmaceuticals (Subject)
Opaleye Management Inc. (Filed by)
Form SC 13G
08/25/2020
7:05 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2020
6:04 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2020
6:03 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2020
9:43 AM
Infinity Pharmaceuticals (Filer)
Form CT ORDER
06/18/2020
3:22 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
7:34 AM
Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
7:33 AM
Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
7:30 AM
BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
7:30 AM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
7:30 AM
EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2020
7:40 AM
Infinity Pharmaceuticals (Filer)
Form DEFA14A
05/11/2020
6:37 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
6:24 AM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/27/2020
7:30 AM
Infinity Pharmaceuticals (Filer)
Form DEF 14A
04/07/2020
6:47 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2020
6:48 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2020
7:00 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
8:58 AM
Infinity Pharmaceuticals (Filer)
Form CT ORDER
01/13/2020
4:01 PM
Infinity Pharmaceuticals (Issuer)
Tasker Seth A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
4:01 PM
BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
4:01 PM
Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
4:00 PM
Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
7:00 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
4:22 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13D/A
01/09/2020
6:43 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
2:13 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2019
6:18 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
6:14 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/22/2019
3:05 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
7:32 AM
Infinity Pharmaceuticals (Filer)
Form 424B5
07/30/2019
6:44 AM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2019
6:35 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
3:26 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:06 PM
EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:06 PM
Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:06 PM
BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:05 PM
Berkowitz Jeffrey (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
6:32 AM
Infinity Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2019
3:56 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
3:11 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
2:16 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2019
11:15 PM
Infinity Pharmaceuticals (Filer)
Form EFFECT
04/24/2019
7:30 AM
Infinity Pharmaceuticals (Filer)
Form DEF 14A
04/08/2019
4:03 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
9:10 AM
Infinity Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/14/2019
6:38 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
6:06 AM
Infinity Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2019
6:53 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2019
7:00 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
3:07 PM
Infinity Pharmaceuticals (Issuer)
Tasker Seth A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:06 PM
BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:05 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:05 PM
Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:46 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
6:40 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
5:28 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2018
4:57 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2018
4:24 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13D/A
11/15/2018
7:07 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
2:33 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/30/2018
11:00 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
4:10 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
4:05 PM
Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2018
3:13 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
2:27 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/26/2018
10:52 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2018
4:00 PM
Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
5:57 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
4:23 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
Form SC 13D/A
06/14/2018
7:37 AM
Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:35 AM
Berkowitz Jeffrey (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:34 AM
Infinity Pharmaceuticals (Issuer)
SMITH IAN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:33 AM
EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:32 AM
Infinity Pharmaceuticals (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:31 AM
Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
7:30 AM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2018
7:30 AM
BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
11:15 PM
Infinity Pharmaceuticals (Filer)
Form EFFECT
05/08/2018
3:12 PM
Infinity Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
2:36 PM
Infinity Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.